Identification of Nutritional Risk Factors and Construction of a Nomogram Prediction Model in AIDS Patients

Why It Matters

Early identification of malnutrition in AIDS patients can guide timely nutritional interventions, potentially improving immune recovery and treatment outcomes. A simple, high‑accuracy tool helps clinicians allocate resources efficiently in resource‑constrained settings.

Key Takeaways

• Low BMI predicts nutritional risk in AIDS patients
• Reduced CD4 count correlates with malnutrition susceptibility
• Serum albumin below 35 g/L indicates protein deficiency
• Nomogram using BMI, CD4, albumin achieves AUC 0.959
• Model offers rapid bedside risk stratification for clinicians

Pulse Analysis

The interplay between HIV infection and nutrition is a two‑way street: the virus accelerates metabolic demand while compromising gut integrity, leading to higher caloric and protein needs. Traditional screening tools like NRS 2002 capture general risk but often miss HIV‑specific nuances, prompting researchers to seek more targeted predictors. By focusing on readily available clinical metrics—BMI, CD4⁺ count, and serum albumin—this study bridges the gap between comprehensive assessment and practical bedside application, offering a streamlined pathway for clinicians to flag patients at imminent risk of malnutrition.

Statistical analysis revealed that each of the three variables independently reduced the odds of adequate nutrition, with odds ratios indicating a strong protective effect of higher values. The resulting nomogram, constructed in R, demonstrated exceptional discriminative power (AUC = 0.959) and maintained calibration after 1,000‑bootstrap resampling, suggesting that the model reliably mirrors real‑world outcomes. Sensitivity of 79% and specificity nearing 98% mean that most at‑risk patients are captured while false positives remain minimal, a balance crucial for directing limited nutritional support resources.

Beyond its immediate clinical utility, the model underscores a broader shift toward precision nutrition in infectious disease care. External validation across diverse cohorts could cement its role in guidelines, while integration with electronic health records would enable automated risk scoring. Future research should explore adding inflammatory markers or body composition data to refine predictions further. Ultimately, such tools can help reduce morbidity, enhance antiretroviral therapy effectiveness, and lower healthcare costs associated with advanced HIV‑related complications.